CTAS
Cintas Corporation
CTAS has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CTAS overall, supported by stronger valuation and stronger modeled upside.
CTAS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
CTAS's revenue, profitability, cash flow and balance sheet are all currently healthy.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CTAS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 35x | $179 | -21% |
| Fair | 39x | $198 | -13% |
| Forward | 40x | $228 | — |
| Current | 45x | $228 | — |
| Expensive | 47x | $239 | +4.9% |
Historical ranges are pointers, not guarantees.
CTAS's PE is in its expensive range at 45x. If earnings grow as analysts expect, today's price would be 40x next year's earnings, in its fair range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CTAS in the historical PE scenario, which offers more potential upside but is not a forecast.
CTAS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for CTAS, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CTAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.71 | +13% |
| Q3 2026 | $5.07 | +13% |
| Q2 2026 | $4.91 | +12% |
| Q1 2026 | $4.73 | +9.5% |
| Q4 2025 | $4.62 | +11% |
| Q3 2025 | $4.50 | +14% |
| Q2 2025 | $4.40 | +16% |
| Q1 2025 | $4.32 | +19% |
| Q4 2024 | $4.15 | +20% |
CTAS's earnings per share have climbed steadily: $5.07 over the past year, up 13% from the year before, and higher year over year every quarter since late 2020.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CTAS on earnings, with stronger typical year-over-year growth.
CTAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3B | +11% |
| Q2 2026 | $2.9B | +8.9% |
| Q1 2026 | $2.8B | +8.9% |
| Q4 2025 | $2.8B | +9.3% |
| Q3 2025 | $2.7B | +8.7% |
| Q2 2025 | $2.7B | +8% |
| Q1 2025 | $2.6B | +8.4% |
| Q4 2024 | $2.6B | +7.8% |
CTAS's revenue has grown year over year for 22 quarters in a row: $3B last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +0.9 points |
| Q2 2026 | 23% | +0.8 points |
| Q1 2026 | 23% | -0.2 points |
| Q4 2025 | 23% | +0.3 points |
| Q3 2025 | 23% | +0.3 points |
| Q2 2025 | 22% | +0.2 points |
| Q1 2025 | 23% | +1.7 points |
| Q4 2024 | 23% | +2.1 points |
CTAS has the edge over VRT on profitability, with a higher operating margin.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CTAS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT's operating margin was 23% last quarter, up 3.5 points from the same quarter a year ago, near the top of its range since 2020.
CTAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464.8M | +49% |
| Q2 2026 | $613.1M | +18% |
| Q1 2026 | $530.6M | +1.6% |
| Q4 2025 | $425M | +25% |
| Q3 2025 | $312.5M | -16% |
| Q2 2025 | $521.1M | -12% |
| Q1 2025 | $522.1M | -5.1% |
| Q4 2024 | $340M | +14% |
CTAS's free cash flow has been positive every quarter for seven years: $2B over the past year, up 20% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CTAS on cash flow, with more consistent year-over-year improvement.
CTAS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -1.9M shares |
| 1 year | -1.2% | -5M shares |
| 3 years | -2.4% | -10M shares |
| 5 years | -4.6% | -19.5M shares |
| Available history | -5.8% | -25.1M shares |
CTAS has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $315.7M |
| Q2 2026 | $18.9M |
| Q1 2026 | $31.6M |
| Q4 2025 | $635.6M |
| Q3 2025 | $266.1M |
| Q2 2025 | $256.7M |
| Q1 2025 | $26.6M |
| Q4 2024 | $36.7M |
CTAS spent $1B buying back its own shares over the past year, up 71% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CTAS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Very low |
CTAS's net debt is less than a year of its operating earnings (EBITDA).
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CTAS on leverage, with a lower net debt burden relative to earnings.
CTAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.7 | Neutral |
| Stochastic | 80.2 | Overbought |
CTAS's weekly RSI is 69 (neutral) and its Stochastic is 80 (overbought).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CTAS PE vs Industrials Sector
| Metric | CTAS | Sector median | Relative |
|---|---|---|---|
| PE | 45x | 24x | 87% above |
| PE % | 77 | 58 | 19 pts above |
CTAS is trading at 45x earnings, a 87% premium to the Industrials sector's median of 24x.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT has the edge over CTAS on valuation relative to its sector.
CTAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $212.9 | 6.9% above |
| 20 week MA | $204.5 | 11% above |
| 50 week MA | $191.7 | 19% above |
| 100 week MA | $198.1 | 15% above |
| 200 week MA | $175.2 | 30% above |
CTAS has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CTAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $67.3 | $84.6 | +26% |
| 2021 | $84.6 | $108.8 | +29% |
| 2022 | $108.8 | $114.3 | +5.1% |
| 2023 | $114.3 | $150.7 | +32% |
| 2024 | $150.7 | $183.4 | +22% |
| 2025 | $183.4 | $191.1 | +4.2% |
| 2026 YTD | $191.1 | $227.5 | +19% |
CTAS has finished every year since 2020 higher, and it's up 19% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CTAS on returns for 2026, with the stronger performance.